Eulav Asset Management Guardant Health, Inc. Transaction History

Eulav Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$20.94 - $38.01 $125,640 - $228,060	-6,000 Reduced 10.0%	54,000 $1.93 Million
Q1 2023 Apr 27, 2023	SELL	$22.92 - $33.76 $343,800 - $506,399	-15,000 Reduced 20.0%	60,000 $1.41 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $1.91 Million - $4.48 Million	75,000 New	75,000 $2.04 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.